Oxford Biomedica CFO Stuart Paynter to step down, Lucinda Crabtree to succeed

Oxford Biomedica (OXBDF) announces the appointment of Lucinda Crabtree Ph.D. as CFO and Board member. Simultaneously, the Company announces that Stuart Paynter will step down as CFO and from the Board after almost seven years of service. These changes will become effective on 2 September 2024 and Stuart will then transition away from Oxford Biomedica following a suitable handover period. Lucinda Crabtree was previously CFO at MorphoSys (MOR)